Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 7;12(1):4171.
doi: 10.1038/s41467-021-24392-2.

Precise spatiotemporal control of voltage-gated sodium channels by photocaged saxitoxin

Affiliations

Precise spatiotemporal control of voltage-gated sodium channels by photocaged saxitoxin

Anna V Elleman et al. Nat Commun. .

Erratum in

Abstract

Here we report the pharmacologic blockade of voltage-gated sodium ion channels (NaVs) by a synthetic saxitoxin derivative affixed to a photocleavable protecting group. We demonstrate that a functionalized saxitoxin (STX-eac) enables exquisite spatiotemporal control of NaVs to interrupt action potentials in dissociated neurons and nerve fiber bundles. The photo-uncaged inhibitor (STX-ea) is a nanomolar potent, reversible binder of NaVs. We use STX-eac to reveal differential susceptibility of myelinated and unmyelinated axons in the corpus callosum to NaV-dependent alterations in action potential propagation, with unmyelinated axons preferentially showing reduced action potential fidelity under conditions of partial NaV block. These results validate STX-eac as a high precision tool for robust photocontrol of neuronal excitability and action potential generation.

PubMed Disclaimer

Conflict of interest statement

J.D. is a cofounder and holds equity shares in SiteOne Therapeutics, Inc., a startup company interested in developing subtype-selective NaV modulators. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Caging STX-ea 1 with photo-protecting groups.
a Synthesis and selective carbamoylation of STX-ea 1. b Photocaged derivatives of STX-ea.
Fig. 2
Fig. 2. Photochemical release of STX-ea 1 results in a block of NaV1.2 CHO.
a Electrophysiological characterization of photocaged STXs against NaV1.2 CHO. IC50s, Hill coefficients: 1 = 14.4 ± 0.3 nM, –0.94 ± 0.02; 2 = 27.0 ± 1.4 nM, –0.94 ± 0.05; 3 = 55.5 ± 2.1 nM, –1.01 ± 0.04; 4 = 307.5 ± 16.6 nM, –1.37 ± 0.09; 5 = 1003.8 ± 42.2 nM, –1.00 ± 0.04. Data represent mean ± s.e.m. (for compound 1 [2, 5, 10 nM], n = 6, [20, 50, 100 nM], n = 7; 2, n = 3; 3, n = 6; 4, n = 6; 5, n = 5). b Electrophysiological characterization and laser uncaging of 5 against NaV1.2 CHO. Initial IC50 in blue; apparent IC50 following laser scan 1 in red (30.4 ±  3.6 nM) and after laser scan 5 in purple (10.4 ± 2.0 nM). Data represent mean ± s.e.m. (n = 5). c Representative trace depicting uncaging of 100 nM 5 against NaV1.2 CHO. Traces collected in the order: Start, 100 nM 5, 0 s, 2 s, 4 s. Laser applied immediately prior to 10 ms, 0 mV voltage step (trace 0 s). d Time course of uncaging of 100 nM 5 against NaV1.2 CHO pulsed from –100 mV to 0 mV at 2.5 Hz. The laser was applied at t = 0 s. Data were subjected to exponential regression yielding τ = 2.3 ± 0.2 s (half-life 1.6 ± 0.1 s), R2 = 0.9056. Data represent mean ± s.e.m. (n = 4). n = number of biologically independent cells.
Fig. 3
Fig. 3. Uncaging of STX-eac 5 results in fast, concentration-dependent NaV block and inhibition of APs.
a Electrophysiological characterization of photocaged STXs against hippocampal neurons DIV 6–8. IC50s, Hill Coefficients: 1 = 14.1 ± 0.8 nM, –0.86 ± 0.04; STX-eac 5 = 2148.4 ± 209.9 nM, –0.83 ± 0.07. Apparent IC50, Hill Coefficient: 5 (uncaged) = 106.0 ± 17.4 nM, –0.71 ± 0.11. Data represent mean ± s.e.m. (for compound 1 [2 nM], n = 4; [5, 10, 20, 50, 100 nM], n = 5. For compound 5 [100 nM], n = 12; [200 nM], n = 10; [500 nM], n = 13; [1 µM], n = 12; [2 µM, 5 µM], n = 4. For compound 5 (uncaged) [100 nM], n = 4; [200 nM], n = 6; [500 nM], n = 5; [1 µM], n = 4.). b Representative trace depicting uncaging of 200 nM 5 against hippocampal neurons DIV 6–8. Traces collected in the order: Start, 200 nM 5, 0 s, 2 s, 4 s. Laser applied immediately prior to 10 ms, 0 mV voltage step (trace 0 s). c Comparison between current-clamp (DIV 9–13, right axis, black) and voltage-clamp (DIV 6–8, left axis, gray) data collected pre- and post-uncaging at various concentrations of 5. T, toxin applied; TL, toxin and laser applied. Statistics calculated for current-clamp data. ns P > 0.5, ***P < 0.001, one-way ANOVA with Tukey’s correction, mean ± s.e.m. T(100 nM) vs. T(200 nM), P = 0.7727; T(100 nM) vs. T(500 nM), P = 1.34 × 10–4; T(200 nM) vs. T(500 nM), P = 8.46 × 10–4; T(500 nM) vs. TL(100 nM), P = 0.9997. (For T(100 nM), n = 9; T(200 nM), n = 19; T(500 nM), n = 5; TL(100 nM), n = 9; TL(200 nM), n = 19; TL(500 nM), n = 5.) n = number of biologically independent cells.
Fig. 4
Fig. 4. Uncaging of 200 nM STX-eac 5 shows reversible inhibition of AP firing.
a Representative traces depicting initial (I), laser applied (L), 200 nM toxin 5 applied (T), 200 nM toxin 5 and laser applied (TL), and recovered (R) after wash-off AP trains evoked by 500 ms, 50–150 pA current injections into hippocampal neurons DIV 9–13. Data taken from replicate current step 2 vis-à-vis (b). b Heatmap summary of data described in a color-coded by the number of action potentials per step (four replicate current steps at 0.25 Hz per condition, n = 19). c Equilibrated normalized action potential firing rate (i.e., over current steps 2–4) pre- and post-laser induced uncaging of 5. ns P > 0.5, ****P < 0.0001, one-way ANOVA with Tukey’s correction, mean ± s.e.m. I vs. L, P = 0.9503; I vs. T, P = 0.4131; L vs. T, P = 0.7437; I vs. TL, P = 2.7 × 10–14; L vs. TL, P = 9.69 × 10–12; T vs. TL, P = 2.38 × 10–8. (n = 19). n = number of biologically independent cells.
Fig. 5
Fig. 5. Uncaging STX-eac 5 differentially affects myelinated vs. unmyelinated callosal fiber transmission.
a Experimental design of corpus callosum preparation. On the left, a representative picture of an experiment. On the right, a corresponding schematic representation, HC stands for the hippocampus; cc for corpus callosum. b Schematic representation of callosal N1 and N2 features. N1 is the fastest component and corresponds mainly to myelinated axon fibers. N2 is slower and corresponds mainly to unmyelinated axon fibers. c Example of LFP and CSD signals for two different concentrations of 5, 250 nM (upper panel) and 500 nM (lower panel). Black traces represent signals before uncaging, gray traces represent signals after uncaging by 500ms UV pulse light delivery. Only the first seven channels closest to the stimulating electrode are represented. The expanded timescale of the first CSD channel is represented on the right. For 250 nM 5, a reduction of amplitude and a delay of the peak time can be observed after uncaging for N2. Only a reduction of amplitude can be observed for N1; peak time was not affected. For 500 nM 5, a loss of N1 and N2 signals can be observed after light delivery. d Scatter plot of the effect of 100 nM bath application of 1 in blue and of the effect of uncaging of 100, 250, and 500 nM 5 on N1 (left graph) and N2 (right graph) amplitude. e Scatter plot of the effect 100 nM bath application of 1 in blue and of uncaging of 100, 250, and 500 nM 5 on the N1 (left) and N2 (middle) peak time. Histograms (on the right) represent the incidence of complete block for N1 (black) and N2 (red) for the three different concentrations of 5, 100, 250, and 500 nM. Increases in peak timing were observed with 100 nM 1 and 500 nM 5 for N1 and with 100 nM 1, 100 nM and 250 nM 5 for N2. Notice that 30% of the slices have a complete block of N2 at 500 nM, obscuring any potential difference in latency. d, e Two-tailed Wilcoxon test (n = 8, 7, 5, and 8, respectively, for 100 nM 1, 100 nM, 250 nM, and 500 nM 5). P values less than 0.05 are highlighted in red. Each pair of connected dots represents the results of a single slice before (filled circle) and after (open circle) light application. For each condition mean ± s.e.m. are represented on each side of the connected dots.

References

    1. Barltrop J, Schofield P. Photosensitive protecting groups. Tetrahedron Lett. 1962;3:697–699.
    1. Liu J, et al. Genetically encoding photocaged quinone methide to multitarget protein residues covalently in vivo. J. Am. Chem. Soc. 2019;141:9458–9462. - PMC - PubMed
    1. Aonbangkhen C, Zhang H, Wu DZ, Lampson MA, Chenoweth DM. Reversible control of protein localization in living cells using a photocaged-photocleavable chemical dimerizer. J. Am. Chem. Soc. 2018;140:11926–11930. - PMC - PubMed
    1. So WH, Wong CT, Xia J. Peptide photocaging: a brief account of the chemistry and biological applications. Chin. Chem. Lett. 2018;29:1058–1062.
    1. Sansalone L, et al. Photopotentiation of the GABAA receptor with caged diazepam. Proc. Natl Acad. Sci. USA. 2019;116:21176–21184. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources